Global PET Radiopharmaceuticals Market Insights and Forecast to 2026

Global PET Radiopharmaceuticals Market Insights and Forecast to 2026

  • QYResearch
  • July 2020
  • Pharmaceutical
  • 112 pages

Report Description

1
1
PET Radiopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PET Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the PET Radiopharmaceuticals market is segmented into
F-18
Ru-82
Others

Segment by Application, the PET Radiopharmaceuticals market is segmented into
Oncology
Cardiology
Neurology
Others

Regional and Country-level Analysis
The PET Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the PET Radiopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and PET Radiopharmaceuticals Market Share Analysis
PET Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in PET Radiopharmaceuticals business, the date to enter into the PET Radiopharmaceuticals market, PET Radiopharmaceuticals product introduction, recent developments, etc.

The major vendors covered:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)

Have query on this report?

Make an Enquiry
1 Study Coverage
1.1 PET Radiopharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key PET Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
List of Tables
Table 1. PET Radiopharmaceuticals Market Segments
Table 2. Ranking of Global Top PET Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global PET Radiopharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of F-18
Table 5. Major Manufacturers of Ru-82

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074